Last reviewed · How we verify
NA picosulfate magnesium citrate — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
NA picosulfate magnesium citrate (NA picosulfate magnesium citrate) — Norgine.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| NA picosulfate magnesium citrate TARGET | NA picosulfate magnesium citrate | Norgine | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- NA picosulfate magnesium citrate CI watch — RSS
- NA picosulfate magnesium citrate CI watch — Atom
- NA picosulfate magnesium citrate CI watch — JSON
- NA picosulfate magnesium citrate alone — RSS
Cite this brief
Drug Landscape (2026). NA picosulfate magnesium citrate — Competitive Intelligence Brief. https://druglandscape.com/ci/na-picosulfate-magnesium-citrate. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab